Tyra Biosciences shares jump on next week Phase 2 readout
Tyra Biosciences said initial clinical results from a key Phase 2 bladder cancer study will be announced next week. Shares were up more than 15% at the time of writing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.